Natco Pharma Ltd. | Income Statement
Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
7,003
7,845
10,272
19,970
21,585
20,945
Cost of Goods Sold (COGS) incl. D&A
4,835
5,230
5,780
9,974
8,916
7,911
Gross Income
2,168
2,615
4,492
9,996
12,669
13,034
SG&A Expense
950
1,191
2,294
3,652
3,895
5,896
EBIT
1,110
1,293
-
6,400
8,527
7,138
Unusual Expense
-
152
25
24
5
-
Non Operating Income/Expense
521
511
93
26
245
1,302
Interest Expense
366
317
229
185
154
193
Pretax Income
1,290
1,342
2,015
6,244
8,872
8,247
Income Tax
309
40
479
1,395
1,920
1,823
Consolidated Net Income
981
1,303
1,536
4,849
6,952
6,424
Net Income
1,027
1,346
1,549
4,860
6,962
6,444
Net Income After Extraordinaries
1,027
1,346
1,527
4,860
6,962
6,444
Net Income Available to Common
1,027
1,346
1,571
4,860
6,962
6,444
EPS (Basic)
6.43
8.13
9.22
27.89
39.26
34.98
Basic Shares Outstanding
160
166
170
174
177
-
EPS (Diluted)
6.43
8.13
9.19
27.87
39.13
-
Diluted Shares Outstanding
160
166
171
174
178
-
EBITDA
1,414
1,766
2,765
6,944
9,189
7,948
Other Operating Expense
108
131
59
56
247
-
Non-Operating Interest Income
25
7
55
79
249
-
Minority Interest Expense
46
43
13
11
10
20
About Natco Pharma
View Profile
